Logo image
Se connecter
Double blind multicenter phase III GORTEC trial evaluating the efficacy of oral immune modulating formulae therapy during adjuvant radiochemotherapy in head and neck squamous cell carcinoma (HNSCC)
Article de revue   Avec comité de lecture

Double blind multicenter phase III GORTEC trial evaluating the efficacy of oral immune modulating formulae therapy during adjuvant radiochemotherapy in head and neck squamous cell carcinoma (HNSCC)

Pierre Boisselier, Pierre Graff-Cailleaud, Christian Sire, Olivier Gallocher, Sandrine Lavau-Denes, Muriel Garcia-Ramirez, Marc Alfonsi, Didier Cupissol, Marie-Christine Kaminsky, Stephanie Fiore, …
Journal of clinical oncology, Vol.33(15_suppl), pp.6066-6066
20/05/2015

Indicateurs

1 Consultations de la notice

Détails

Logo image